scispace - formally typeset
Journal ArticleDOI

Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart.

TLDR
Reductions in fatty acid oxidation and lipid incorporation rates were accompanied by downregulation of the cardiac fatty acid transporters, and the metabolic shift away from fatty acid utilisation was proportional to the degree of functional impairment in the chronically infarcted rat heart.
Abstract
Objectives: Cardiac fatty acid uptake occurs predominantly via sarcolemmal transporter proteins; fatty acid translocase (FAT/CD36), plasma membrane fatty acid binding protein (FABPpm) and fatty acid transporter proteins (FATP) 1 and 6. We hypothesised that levels of the fatty acid transporters would be reduced in the chronically infarcted rat heart, in parallel with reduced dependence on fatty acid utilisation. Methods and results: In vivo left ventricular ejection fractions, measured using echocardiography, were 36% lower in rats six months after coronary artery ligation than in sham-operated control rats. In isolated, perfused, infarcted hearts, 3H-palmitate oxidation was 30% lower, and correlated with in vivo ejection fractions. As myocardial lipid incorporation was also reduced by 25%, total palmitate utilisation was 29% lower in the infarcted rat heart. The protein levels of the cardiac fatty acid transporters were reduced in the infarcted rat heart; FAT/CD36 by 36%, FABPpm by 12%, FATP6 by 21% and FATP1 by 26%, and the cytosolic fatty acid binding protein (cFABP) was 47% lower than in sham-operated rat hearts. Fatty acid transporter levels correlated with both palmitate oxidation rates and cardiac ejection fractions. Conclusions: Reductions in fatty acid oxidation and lipid incorporation rates were accompanied by downregulation of the cardiac fatty acid transporters. The metabolic shift away from fatty acid utilisation was proportional to the degree of functional impairment in the chronically infarcted rat heart.

read more

Citations
More filters
Journal ArticleDOI

Myocardial Fatty Acid Metabolism in Health and Disease

TL;DR: The regulation of myocardial fatty acid beta-oxidation is reviewed and how alterations in fatty acid Beta-Oxidation can contribute to heart disease is discussed.
Journal ArticleDOI

Cardiac metabolism in heart failure: implications beyond ATP production.

TL;DR: It is highlighted that metabolic remodeling in HF not only results in impaired cardiac energetics but also induces other processes implicated in the development of HF such as structural remodeling and oxidative stress, which may have significant therapeutic relevance that goes beyond the energetic aspect.
Journal ArticleDOI

Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease

TL;DR: In this article, it was shown that following an acute stimulus, particularly insulin or muscle contraction, specific fatty acid transporters translocate from intracellular stores to the plasma membrane to facilitate fatty acid uptake.
Journal ArticleDOI

Physiological and pathological cardiac hypertrophy

TL;DR: The key molecules and cellular responses involved in physiological/pathological cardiac hypertrophy are described, which lead to maladaptive cardiac remodeling and heart failure.
Journal ArticleDOI

Metabolic remodelling in heart failure

TL;DR: It is suggested that the alterations of intermediate substrate metabolism and oxidative stress rather than an ATP deficit per se account for maladaptive cardiac remodelling and dysfunction under resting conditions.
References
More filters
Book ChapterDOI

[1] Citrate synthase. [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)]

TL;DR: This chapter is dedicated to describing citrate synthase, which can be followed by measuring the appearance of the free SH group of the released CoASH through three methods discussed in the chapter.
Journal ArticleDOI

Myocardial Substrate Metabolism in the Normal and Failing Heart

TL;DR: This review discusses the metabolic changes that occur in chronic heart failure, with emphasis on the mechanisms that regulate the changes in the expression of metabolic genes and the function of metabolic pathways and the consequences of these metabolic changes on cardiac function.
Journal ArticleDOI

Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein.

TL;DR: Immunocytochemistry and subcellular fractionation of 3T3-L1 adipocytes show that FATP is localized to the plasma membrane, and it is proposed thatfatP is a plasma membrane transporter for LCFAs.
Journal ArticleDOI

Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice.

TL;DR: It is concluded that CD36 facilitates a large fraction of fatty acid uptake by heart, skeletal muscle, and adipose tissues and thatCD36 deficiency in humans is the cause of the reported defect in myocardial BMIPP uptake.
Journal ArticleDOI

Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart

TL;DR: Findings identify a gene regulatory pathway involved in the control of cardiac energy production during the development of HF, which is thought to maintain aerobic energetic balance.
Related Papers (5)